Lupin informs about press release

12 Nov 2018 Evaluate

Lupin has informed about a Press Release as regards receipt of Establishment Inspection Report from the USFDA, post the completion of a Pre-Approval Inspection for Phenytoin Sodium Extended Release 100 mg capsules, at the Company's Nagpur facility in Maharashtra. The inspection conducted in September 2018 concluded without any observations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2138.65 -12.40 (-0.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×